Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells

Blood

Volumn 90, Issue 3, 1997, Pages 1175-1185

  Benedetti, Laura ^b   Levin, Arthur A ^b   Scicchitano, Bianca M ^b   Grignani, Francesco ^b   Allenby, Gary ^b   Diverio, Daniela ^b   Lo Coco, Francesco ^b   Avvisati, Giuseppe ^b   Ruthardt, Martin ^b   Adamo, Sergio ^b   Pelicci, Pier Giuseppe ^b   Nervi, Clara ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; RETINOIC ACID; RETINOID;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR BINDING;

EID: 0030741086     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.1175     Document Type: Article

References (55)

1. Longo L, Pandolfi PP, Biondi A, Rambaldi A, Mencarelli A, Lo Coco F, Diverio D, Pegoraro L, Avanzi G, Tabilio A, Zangrilli D, Alcalay M, Donti E, Grignani F, Pelicei PG: Rearrangements and aberrant expression of the retinoic acid receptor α gene in acute promyelocytic leukemia. J Exp Med 172:1571, 1990
2. Miller WH Jr, Warrell RP Jr, Frankel SR, Jakubowski A, Gabrilove JL, Muindi J, Dmitrovsky E: Novel retinoic acid receptor-α transcripts in acute promyelocytic leukemia responsive to all-trans-retinoic acid. J Natl Cancer Inst 82:1932, 1990
3. Warrell RP Jr, de Thé H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
4. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Grignani F, Lo Coco F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
5. Pandolfi PP, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Structure and origin of the acute promyelocytic leukemia my1/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285, 1991
6. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub MP, Durand B, Lanotte M, Berger R, Chambon P: Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J 11:629, 1992
7. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM: Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663, 1991
8. de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
9. Chen Z, Brand NJ, Chen A, Chen S-J, Tong JH, Wang Z-Y, Waxman S, Zelent A: Fusion between a novel Kruppel-like zinc finger gene and retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia. EMBOJ 12:1161, 1993
10. Licht JD, Chomienne C, Goy A. Chen A, Scott AA, Head DR, Michaux JL, Wu Y, Deblasio A, Miller WH Jr, Zelenetz AD, Willman CL, Chen Z, Chen SJ, Zelent A, Macintyre E, Veil A, Cortes J, Kantarjian H, Waxman S: Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85:1083, 1995
11. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ: The t(5;17) variant of acute promyelocytic leukemia expresses a nucleo-phosmin-retinoic acid receptor fusion. Blood 87:882, 1996
12. Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastang C, Castaigne S, Fenaux P: All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
13. Huang W, Sun GL, Li XS, Cao Q, Lu Y, Jang GS, Zhang FQ, Chai JR, Wang Z, Waxman S, Chen Z, Chen SJ: Acute promyelocytic leukemia: Clinical relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotran-scriptase/polimerase chain reaction to predict relapse. Blood 82:1264, 1993
14. Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA, Warrell RP Jr: Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low dose chemotherapy, PMN/RAR-α isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 84:3843, 1994
15. Sporn MB, Roberts AB, Goodman DS: The Retinoids: Biology, Chemistry and Medicine. New York, NY, Raven, 1994
16. Blomhoff R: Vitamin A in Health and Disease. New York, NY, Dekker, 1994
17. Allenby G, Bocquel T, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P, Levin AA: Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90:30, 1993
18. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397, 1992
19. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowsky T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A, Grippo JF: 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355:359, 1992
20. Nervi C, Poindexter EC, Grignani F, Pandolfi PP, Lo Coco F, Avvisati G, Pelicci PG, Jetten AM: Characterization of the PML-RARα chimeric product of the acute promyelocytic leukemia specific t(15;17) translocation. Cancer Res 52:3687, 1992
21. Rochette-Egly C, Lutz Y, Saunders M, Gaub MP, Chambon P: Retinoid acid receptor gamma specific immunodetection and phosphorylation. J Cell Biol 115:535, 1991
22. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:620, 1985
23. Biondi A, Rambaldi A, Alcalay M, Pandolfi PP, Lo Coco F, Diverio D, Rossi V, Mencarelli A, Longo L, Zangrilli D, Masera G, Barbui T, Mandelli F, Grignani F, Pelicci PG: RARα rearrangements as genetic markers for diagnosis and monitoring in acute promyelocytic leukemia. Blood 77:1418, 1991
24. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
25. Brand N, Petkovich M, Krust A, Chambon P, de Thé H, Marchio A, Tiollais P, Dejean A: Identification of a second human retinoic acid receptor. Nature 332:850, 1988
26. Krust A, Kastner P, Petkovich M, Zelent A, Chambon P: A third human retinoic acid receptor, hRAR-gamma. Proc Natl Acad Sci USA 86:5310, 1989
27. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224, 1990
28. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM: Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6:329, 1992
29. Dugaicyzk AD, Haron JA, Stone EM, Dennison OE, Rothblum KN, Schwartz RJ: Cloning and sequencing of a ribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. Biochemistry 22:1605, 1983
30. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F, Rochette-Egly C, Gaub MP, Chambon P, Pelicci PG: Genomic variability and alternative splicing generate multiple PML/RARa transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocitic leukaemia. EMBO J 11:1397, 1992
31. Nervi C, Grippo JF, Sherman MI, George MD, Jetten AM: Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells. Proc Natl Acad Sci USA 86:5854, 1989
32. Jetten AM, Grippo JF, Nervi C: Isolation and binding characteristics of nuclear retinoic acid receptors, in Packer L (ed): Methods in Enzymology, vol "Retinoids." San Diego, CA, Academic, 1990, p 248
33. Rodbard D: Mathematics of hormone-receptor interaction. Basic principles, in O'Malley BW, Means AR (eds): Receptors for Reproductive Hormones. New York, NY, Plenum, 1973, p 289
34. DeLean A, Munson PJ, Rodbard D: Simultaneous analysis of families of sigmoidal dose curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97, 1973
35. de Thé H, delMar Vivanco-Ruiz M, Tiollais P, Stunnenberg H, Dejean A: Identification of a retinoic acid response element in the retinoic acid receptor β gene. Nature 343:177, 1990
36. de Verneuil H, Metzger D: The lack of transcriptional activation of the v-erbA oncogene is part due to a mutation present in the binding domain of the protein. Nucleic Acids Res 18:4489, 1990
37. Giguere V: Application of the firefly luciferase reporter gene, in Murray EJ (ed): Gene Transfer and Expression Protocols. Methods in Molecular Biology. Clifton, NJ, Humana, 1991, p 237
38. Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pelicci PG, Nervi C: Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARα-mediated increase of type II transglutaminase. Blood 87:1939, 1996
39. Petkovich M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444, 1987
40. Giguere V, Ong ES, Segui P, Evans RM: Identification of a new class of steroid hormone receptors. Nature 331:91, 1988
41. Allegretto EA, McClurg MR, Lazarchik SB, Clemm DL, Kerner SA, Elgort MG, Boehm MF, White SK, Pike JW, Heyman RA: Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. J Biol Chem 268:26625, 1993
42. Nervi C, Vollberg TM, Grippo JF, Lucas DA, George MD, Sherman MI, Shudo K, Jetten AM: Expression of nuclear retinoic acid receptors in wilde type and mutant embryonal carcinoma PCC4.aza1R cells. Cell Growth Differ 1:535, 1990
43. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 83:841, 1995
44. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A: The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 347:558, 1990
45. Goddard AD, Borrow J, Freemont P, Solomon E: Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254:1371, 1991
46. Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F: AIDA (all-rrans-retinoic acid plus Idarubicin) in newly diagnosed acute promyelocytic leukemia: A GIMEMA pilot study. Blood 88:1390, 1996
47. Miller WH, Jr, Kakizuka A, Frankel SR, Warrell RP Jr, Levine K, Evans RM, Dmitrovsky E: Reverse transcriptase/polymerase chain reaction amplification for PML/RAR-α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89:2694, 1992
48. Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH: Characterization of acute promyelocytic leukemia cases with PML-RARα break/fusion sites in PML exon 6: Identification of a subgroup with decreased in vitro responsiveness to all-trans-retinoic acid. Blood 86:1540, 1995
49. Claston DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Deisseroth AB: Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocitic leukemia. Blood 80:582, 1992
50. Fukutani H, Naoe T, Ohno R, Yoshida H, Miyawaki S, Shimazaki C, Miyake T, Nakayama Y, Kobayashi H, Goto S, Takeshita A, Kobayashi S, Kato Y, Shiraishi K, Sasada M, Ohtake S, Murakami H, Kobayashi M, Endo N, Shindo H, Matsushita K, Hasegawa S, Tsuji K, Ueda Y, Tominaga N, Furuya H, Inoue Y, Takeuchi J, Morishita H, Iida H: Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-frans-retinoic acid. Leukemia 9:1478, 1995
51. Tate BF, Allenby G, Janocha R, Kazmer S, Speck J, Sturzenbecker LJ, Abarzùa P, Levin AA, Grippo JF: Distinct binding determinants for 9-cis-retinoic acid are located within AF-2 of retinoic acid receptor α. Mol Cell Biol 14:2323, 1994
52. Danielian PS, White R, Lees JA, Parker MG: Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025, 1992
53. Tate BF, Grippo JF: Mutagenesis of the ligand binding domain of the human retinoic acid receptor α identifies critical residues for 9-cis-retinoic acid binding. J Biol Chem 270:20258, 1995
54. Chen Z, Guidez F, Rousselot P, Agadira A, Chen S-J, Wang Z-Y, Degos L, Zelent A, Waxman S, Chomienne C: PLZF-RARα fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci USA 91:1178, 1994
55. Mangelsdorf DJ, Umesono K, Evans RM: The retinoid receptors, in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids: Biology, Chemistry, and Medicine. New York, NY, Raven, 1994, p 319